Introduction
Mechanisms exist in the body to prevent the mountbe involved in insulin resistance. Autoantibodies to endogenous peptides are rare but are illustrated in ing of an immune response against the body's own constituents. Spontaneous or exogenously-induced the case of insulin again, with the development of anti-insulin antibodies, in patients who have never flaws in immunological tolerance may however develop, and autoantibodies then occur. Such antireceived exogenous insulin. These insulin autoantibodies are associated with autoimmune insulin synbodies are well-characterized, and include antibodies directed against cells, cellular components and pepdrome which results in spontaneous or reactive hypoglycaemia with high circulating concentrations tides. Autoantibodies to cells include the antral gastrin (G) cell, which in some cases of antral gastritis of total immuno-reactive insulin.5 Pernicious anaemia (PA) is associated with autowould suggest an autoimmune aetiology.1,2 Other cellular antibodies include those to the pancreatic antibodies to intrinsic factor6 and the parietal cell.7 In PA, gastrin levels are normally, but not invariably, islet cell, which were discovered in 1974 and provide a marker for anti-islet autoimmunity in normoglyelevated as a consequence of achlorhydria due to the absence of the negative feedback mechanism.8,9 caemic patients.3,4 Antibodies to cellular components include antimitochondrial antibodies, antinuclear
We have investigated the existence and prevalence of autoantibodies to gastrin in plasma samples anaantibodies and antinucleolar antibodies. Antibodies to exogenous peptides such as insulin are described. lysed in our laboratory, with particular interest in patients with hypergastrinaemia and other autoThese may be induced in response to any form of injected insulin, and evidence suggests that they may immune disease.
phosphate buffer (pH 7.4, 0.05M) containing bovine Methods albumen (RIA grade, 0.2g%). The column was calibrated using rabbit gamma globulin and 125I gastrin-17.
Patients
Elution was with phosphate buffer at a flow rate of In this laboratory we provide a routine diagnostic 4 ml/h at 4°C. Patient plasma (2 ml) was applied to service for all of Northern Ireland, which has a the column and the eluted fractions were assayed in population of 1.6 million. We have processed in the absence of assay antibody (assessment of endoexcess of 50 000 plasma samples for routine gastrin genous antibody) and in the presence of assay analysis over a 25-year period. These samples have antibody (assessment of endogenous gastrin). Total included more than 2000 specimens from PA gastrin fraction from acid treatment and Sep Pac patients. Patients are diagnosed as having PA if they purification of patient plasma was also applied to have autoantibodies to intrinsic factor or parietal the column, eluted and assayed under the same cells, megaloblastic anaemia and are successfully conditions. (vi) Acid-purified antibody from patient treated by vitamin B12 replacement therapy. Patients plasma was used to construct calibration curves whose blood specimens were sent to this laboratory where 125I gastrin was used as tracer and human for routine analysis of gastrin were included in G17 as standard. this study.
Results

Measurements
The plasma from three patients in the total group Routinely, circulating gastrin concentration is estimstudied (more than 50 000 subjects) showed the ated in whole plasma.10 An antibody is used which ability to bind 125I gastrin in the absence of assay was raised to human gastrin 17 conjugated to chicken antibody. All three patients with autoantibodies to egg albumen. It detects amidated gastrins only, and gastrin had pernicious anaemia (more than 2000 measures G34 and G17 in equimolar quantities.
patients, in the total group, had pernicious anaemia). Human gastrin 17 is used as standard in concentraClinical details from these three patients with positive tions between 1.56 and 100 pmol/l. Radiolabelled antigastrin autoantibodies, are shown below. gastrin tracer is used in the assay at 11 pmol/l. Radioimmunoassay (RIA) is used where antibody-
Patient 1
bound is separated from free antigen using dextrancoated charcoal. Lack of an alcohol extraction step A 42-year-old male with insulin-dependent diabetes (where large-sized proteins are removed from the mellitus who was diagnosed at the age of 4 years. system), along with the estimation of non-specific He suffered frequent hypoglycaemic episodes in interference by the inclusion of blank tubes for every childhood and adolescence. PA was diagnosed at plasma sample (where assay antibody is omitted), the age of 36 years, and he was commenced on results in an estimation of endogenous antibody to vitamin B12. His mother had pernicious anaemia gastrin which may be present in the plasma. and diabetes mellitus. In addition to antigastrin Where autoantibodies to gastrin were detected, antibodies, he was also positive for antithyroid antithe following procedures were followed. (i) bodies and antibodies to intrinsic factor. He was not Quantification of endogenous antibody in plasma dyspeptic. was made by assessment of plasma binding to 125I-labelled gastrin under RIA conditions using serial Patient 2 dilutions of the plasma. (ii) Affinity of endogenous antibody was assessed by the ability of the plasma A 35-year-old female who had rheumatoid arthritis to bind 125I-labelled gastrin tracer and assessment of diagnosed at the age of 27, when she presented with the displacement of the labelled gastrin with low pain and swelling of her hands and feet during concentrations of standard gastrin. (iii) Estimation of pregnancy. She also suffered from allergic rhinitis. circulating free gastrin was made after plasma extrac-PA was diagnosed at the age of 34 and she was tion with alcohol. (iv) Evaluation of total gastrin and commenced on vitamin B12. Her brother suffered total antibody was made after acid treatment of from rheumatoid arthritis. In addition to antigastrin plasma, which results in dissociation of antibodyantibodies, she was also positive for antiparietal cell bound antigen. The pH of the plasma was decreased antibodies. She was not dyspeptic. to <2.0, and the products were purified by Sep Pac and assayed for gastrin and antigastrin antibody.
Patient 3
(v) Endogenous antibody and gastrin was purified using gel chromatography. A column (G100, A 78-year-old female who had a past history of mild hypertension. Vitamin B12 was low, and a diagnosis 1.0×100 cm) was prepared and equilibrated with of PA was made. Treatment was commenced. She tested positive for cell, antinuclear and thyromicrosomal antibodies, in addition to antigastrin antibodies, antiparietal cell antibodies and intrinsic factor antibody. She was not dyspeptic.
All three patients
Free gastrin levels in extracted plasma were within the normal range for this laboratory (0-40 pmol/l), while gastrin levels in whole plasma were increased in two of the three patients (50 and 69 pmol/l). Total, antibody-bound and free gastrin levels, however, were elevated in all three patients at 129, 233 and Figure 1 . Antibody dilution curves under radioimmuno-317 pmol/l. Total gastrin was 10 to 14.0 times higher assay conditions using plasma from the three patients with than free plasma gastrin as measured in extracted antibody to gastrin. No control patient showed binding to plasma and five times higher than free gastrin, labelled gastrin >3% at any dilution. measured directly in plasma (Table 1) .
Autoantibodies to gastrin found in all three patients were of low titre and relatively high affinity. At a dilution of 1510, the plasmas bound between 45 and 58% of 125I-labelled gastrin (Figure 1) .
With gel chromatography, two peaks were eluted, one corresponding to globulins in molecular size and capable of binding to labelled gastrin, and the second of small molecular size, corresponding to gastrin. When plasma was acid-treated and purified with Sep Pac, and the gastrin fraction applied to gel filtration, the globulin peak was absent and the quantity of gastrin increased. The results of chromatography for patient 3 are illustrated in Figure 2 . 
Discussion
In this laboratory, autoantibodies to gastrin were readily detectable because of the methodology routinely used for the assay of gastrin in plasma. The rarity of antigastrin autoantibody is emphasized by the extremely low incidence. It is significant that all autoantibodies were associated with pernicious anaemia and the presence of other autoimmune disorders. three patients suffered from PA in addition to other autoimmune disorders. None of the patients showed Gastrin autimmunity was not associated with peptic ulcer disease, and there was no evidence to suggest dyspeptic symptoms, and there was no particular syndrome directly associated with the gastrin autoany deleterious effect of the antigastrin antibodies. immunity. The ability of patient plasma to bind gastrin tracer has clearly been shown to be the result of endogenous antibodies, rather than the result of
